Mirum Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
54.75
|
|
Average Rating
|
4.63
|
|
# Strong Buys
|
5
|
|
# Buys
|
3
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.07
|
-1.02
|
0.05
|
4.67%
|
|
2022-06-30
|
-1.15
|
-0.84
|
0.31
|
26.96%
|
|
2022-03-31
|
-1.34
|
-1.17
|
0.17
|
12.69%
|
|
2021-12-31
|
0.35
|
1.90
|
1.55
|
442.86%
|
|
2021-09-30
|
-1.73
|
-1.55
|
0.18
|
10.40%
|
|
2021-06-30
|
-0.65
|
-1.45
|
-0.80
|
-123.08%
|
|
2021-03-31
|
-0.69
|
-1.68
|
-0.99
|
-143.48%
|
|
2020-12-31
|
-0.72
|
-1.43
|
-0.71
|
-98.61%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.03
|
|
2021-12-31
|
-2.78
|
|
2020-12-31
|
-4.08
|
|
2019-12-31
|
-2.82
|